FOR INVESTORS

Investors & Media

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Ardelyx's financial performance into perspective.

NASDAQ: ARDX

$13.25

- 0.10 (-0.75%)

4:00 PM ET on Mar 24, 2017

Delayed at least 20 minutes.

NEWS

Feb 27, 2017

Ardelyx Announces Presentation at Cowen and Company 37th Annual Healthcare Conference

FULL ARTICLE

Feb 17, 2017

Ardelyx Reports Clinical Progress and Fourth Quarter and Full Year 2016 Financial Results

FULL ARTICLE

EVENTS & PUBLICATIONS

Mar 6, 2017 at 4:00 PM ET

Cowen and Company 37th Annual Healthcare Conference

READ MORE

Feb 15, 2017 at 8:30 AM ET

Ardelyx Clinical Update

READ MORE

Jan 10, 2017 at 3:30 PM PT

J.P. Morgan 35th Annual Healthcare Conference

READ MORE

RESOURCES